> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# $2.25 mil. RWD Funding Opportunity
- URL: https://www.fdaweb.com/2-25-mil-rwd-funding-opportunity/
- Published: 2022-12-13T12:00:00.000Z
- Updated: 2026-09-14T18:09:41.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153382

CDER and CBER are announcing a funding opportunity of up to $2.25 million per award for a project to support the use of real-world data (RWD) to generate real-world evidence (RWE) in regulatory decision-making. The funding [notice](https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-23-025.html?utm%5Fmedium=email&utm%5Fsource=govdelivery) says its purpose is to address topics related to FDA’s real-world evidence program and to enable the agency to assess the potential utility of real-world data in generating real-world evidence.

FDA says the primary objectives of the funding opportunity are to improve the quality and/or use of RWD, promote better understanding of RWE study designs, and develop specific tools to evaluate aspects of RWE generation. The agency says it encourages a variety of project types applicable to drugs and biologics (excluding devices).

Applications are due by 2/28/23.